Assignee
ONCOSOL LTD
GB·2 granted patents·2 pending applications·0 citations·filing 2019–2025
Top patents by PatentIndex Score
4 records- 0171US2024374516A1Ready to use oral pharmaceutical suspension of dasatinibONCOSOL LTD·Filed 2024·Application pending·0 cites
- 0266US12303504B2Non-aqueous chemotherapeutic suspensions for oral dosageONCOSOL LTD·Filed 2019·Granted May 20, 2025·0 cites·14 claims
- 0366US12083222B2Chemotherapeutic pharmaceutical suspension for oral dosageONCOSOL LTD·Filed 2019·Granted Sep 10, 2024·0 cites·20 claims
- 0453US2025170123A1Non-aqueous oral suspension of temozolomideONCOSOL LTD·Filed 2025·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →